| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |